Massachusetts Financial Services CO Alnylam Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$151.41 - $196.57 $87.2 Million - $113 Million	-575,988 Reduced 83.69%	112,240 $21.5 Million
Q3 2023 Nov 08, 2023	BUY	$170.77 - $211.65 $2.7 Million - $3.35 Million	15,831 Added 2.35%	688,228 $122 Million
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $17.3 Million - $19.8 Million	-93,375 Reduced 12.19%	672,397 $128 Million
Q1 2023 May 10, 2023	BUY	$182.66 - $235.53 $1.87 Million - $2.41 Million	10,230 Added 1.35%	765,772 $153 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $40.8 Million - $53.1 Million	219,943 Added 41.06%	755,542 $180 Million
Q3 2022 Nov 09, 2022	BUY	$138.54 - $232.0 $26.5 Million - $44.4 Million	191,310 Added 55.57%	535,599 $107 Million
Q2 2022 Aug 09, 2022	BUY	$120.42 - $169.29 $5 Million - $7.03 Million	41,546 Added 13.72%	344,289 $50.2 Million
Q1 2022 May 11, 2022	SELL	$127.18 - $173.91 $130 Million - $177 Million	-1,019,468 Reduced 77.1%	302,743 $49.4 Million
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $6.87 Million - $9.02 Million	-43,076 Reduced 3.16%	1,322,211 $224 Million
Q3 2021 Nov 10, 2021	SELL	$169.75 - $207.73 $1.67 Million - $2.05 Million	-9,856 Reduced 0.72%	1,365,287 $258 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $11.2 Million - $15.4 Million	-86,919 Reduced 5.94%	1,375,143 $233 Million
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $38.2 Million - $52.9 Million	-301,305 Reduced 17.09%	1,462,062 $206 Million
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $17.5 Million - $20.9 Million	-142,023 Reduced 7.45%	1,763,367 $229 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $102 Million - $139 Million	842,211 Added 79.22%	1,905,390 $277 Million
Q2 2020 Aug 11, 2020	BUY	$104.21 - $156.44 $111 Million - $166 Million	1,063,179 New	1,063,179 $157 Million

Others Institutions Holding ALNY

# of Institutions

650

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.23M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.48 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.43 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.59 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.42 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.34 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account